362 related articles for article (PubMed ID: 18707190)
1. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.
Falagas ME; Vardakas KZ
Drug Saf; 2008; 31(9):753-68. PubMed ID: 18707190
[TBL] [Abstract][Full Text] [Related]
2. Linezolid: a review of its use in the management of serious gram-positive infections.
Perry CM; Jarvis B
Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
4. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
5. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
Hau T
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
[TBL] [Abstract][Full Text] [Related]
7. Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2005; 23(9):945-64. PubMed ID: 16153136
[TBL] [Abstract][Full Text] [Related]
8. Linezolid: an oxazolidinone antimicrobial agent.
Fung HB; Kirschenbaum HL; Ojofeitimi BO
Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
Wilcox MH
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
[TBL] [Abstract][Full Text] [Related]
10. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
11. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
12. Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
Burkhardt O; Pletz MW; Mertgen CP; Welte T
Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):123-30. PubMed ID: 18221168
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Beibei L; Yun C; Mengli C; Nan B; Xuhong Y; Rui W
Int J Antimicrob Agents; 2010 Jan; 35(1):3-12. PubMed ID: 19900794
[TBL] [Abstract][Full Text] [Related]
15. Linezolid versus vancomycin for skin and soft tissue infections.
Yue J; Dong BR; Yang M; Chen X; Wu T; Liu GJ
Cochrane Database Syst Rev; 2013 Jul; (7):CD008056. PubMed ID: 23846850
[TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
Corti G; Cinelli R; Paradisi F
Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
[TBL] [Abstract][Full Text] [Related]
17. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Krueger WA; Unertl KE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
[TBL] [Abstract][Full Text] [Related]
18. Linezolid.
Narang M; Gomber S
Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
[TBL] [Abstract][Full Text] [Related]
19. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]